Trial Profile
Phase I trial investigating the safety, tolerability, and pharmacokinetics of single and repeat oral doses of BC 3781 in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Sep 2013
Price :
$35
*
At a glance
- Drugs Lefamulin (Primary)
- Indications Bacterial infections; Community-acquired pneumonia; Respiratory tract infections; Skin and soft tissue infections
- Focus Adverse reactions; Pharmacokinetics
- 24 Sep 2013 New trial record